Ensayos Clínicos con Enzalutamida en Cancer de Próstata
Death
First‐line
hormonal
th /
Docetaxel/ chemotherapy
Enzalutamide
Sipuleucel‐T
Abiraterone
R di
223
ume
erapy
castration
a um‐
UPWARD
AFFIRM
Tumour vol
Local
therapy*
E l
id
TERRAIN
STRIVE
EMBARK
PREVAIL
ARCHES
nza utam e
Abiraterone
Cabazitaxel
Radium‐223
PRESIDE
PLATO
NCT01302041
Asymptomatic
PROSPER
Symptoms
Time
Hormone sensitive
Castration resistant
Phase 2
Phase 3
Phase 4
§ Selection only
* For example, surgery, radiotherapy ^ Per clinical practice.
